View in EDS

A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.

Saved in:
Bibliographic Details
Title: A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.
Authors: Dolan M; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Shi Y; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Long MD; Department of Bioinformatics and Statistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., McKenery A; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Hill JW; Jacobs School of Medicine and Biomedical Sciences, SUNY at Buffalo, Buffalo, New York., Vaghi C; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Benzekry S; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Barbi J; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Ebos JML; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Sep 04; Vol. 23 (9), pp. 1241-1260.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38690835
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dolan+M%22">Dolan M</searchLink>; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Shi+Y%22">Shi Y</searchLink>; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Mastri+M%22">Mastri M</searchLink>; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Long+MD%22">Long MD</searchLink>; Department of Bioinformatics and Statistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22McKenery+A%22">McKenery A</searchLink>; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Hill+JW%22">Hill JW</searchLink>; Jacobs School of Medicine and Biomedical Sciences, SUNY at Buffalo, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Vaghi+C%22">Vaghi C</searchLink>; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Benzekry+S%22">Benzekry S</searchLink>; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Barbi+J%22">Barbi J</searchLink>; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Ebos+JML%22">Ebos JML</searchLink>; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2024 Sep 04; Vol. 23 (9), pp. 1241-1260.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38690835
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-24-0139
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1241
    Titles:
      – TitleFull: A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dolan M
      – PersonEntity:
          Name:
            NameFull: Shi Y
      – PersonEntity:
          Name:
            NameFull: Mastri M
      – PersonEntity:
          Name:
            NameFull: Long MD
      – PersonEntity:
          Name:
            NameFull: McKenery A
      – PersonEntity:
          Name:
            NameFull: Hill JW
      – PersonEntity:
          Name:
            NameFull: Vaghi C
      – PersonEntity:
          Name:
            NameFull: Benzekry S
      – PersonEntity:
          Name:
            NameFull: Barbi J
      – PersonEntity:
          Name:
            NameFull: Ebos JML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 09
              Text: 2024 Sep 04
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1